Peptide Therapeutics Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Peptide Therapeutics Market 

5.1. COVID-19 Landscape: Peptide Therapeutics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Peptide Therapeutics Market, By Application

8.1. Peptide Therapeutics Market, by Application, 2023-2032

8.1.1. Gastrointestinal Disorder

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Metabolic Disorder

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Neurological Disorder

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Cancer

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Peptide Therapeutics Market, By Type

9.1. Peptide Therapeutics Market, by Type, 2023-2032

9.1.1. Generic

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Innovative

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Peptide Therapeutics Market, By Route of Administration 

10.1. Peptide Therapeutics Market, by Route of Administration, 2023-2032

10.1.1. Oral

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Parenteral

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Pulmonary

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Mucosal

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Peptide Therapeutics Market, By Distribution Channel

11.1. Peptide Therapeutics Market, by Distribution Channel, 2023-2032

11.1.1. Hospital Pharmacies

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Retail Pharmacies

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Online Drug Stores

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Peptide Therapeutics Market, By Synthesis Technology

12.1. Peptide Therapeutics Market, by Synthesis Technology, 2023-2032

12.1.1. Solid Phase peptide Synthesis (SPPS)

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Liquid Phase Peptide Synthesis (LPPS)

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Hybrid Technology

12.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Peptide Therapeutics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Application (2020-2032)

13.1.2. Market Revenue and Forecast, by Type (2020-2032)

13.1.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.1.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.1.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.1.6.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Type (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.1.7.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Application (2020-2032)

13.2.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.2.4. Market Revenue and Forecast, by Distribution Channel (2020-2032) 

13.2.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.2.7. Market Revenue and Forecast, by Distribution Channel (2020-2032) 

13.2.8. Market Revenue and Forecast, by Synthesis Technology (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Application (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.2.10. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.11. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Application (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.13. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Application (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.15. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Application (2020-2032)

13.3.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.3.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Application (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.9. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.10.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.11.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Application (2020-2032)

13.4.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.4.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Application (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.9. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.10.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.11.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Application (2020-2032)

13.5.2. Market Revenue and Forecast, by Type (2020-2032)

13.5.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.5.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Application (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.5.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.5.8.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)

Chapter 14. Company Profiles

14.1. Eli Lilly & Company

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Amgen Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Pfizer, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ever Neuro Pharma GmbH

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bausch Health

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Abbvie

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms